Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Assessment of the Accuracy of a Novel Cellular-Level Fluorescence-Guided Imaging Technique in Scanning Tumor Margins During Breast Tumor Resection: A Prospective, Self-Controlled Study

NCT07311317 is registered in ClinicalTrials.gov with West China Hospital as lead sponsor.

NCT NCT07311317
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07311317 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Assessment of the Accuracy of a Novel Cellular-Level Fluorescence-Guided Imaging Technique in Scanning Tumor Margins During Breast Tumor Resection: A Prospective, Self-Controlled Study
Lead sponsor
West China Hospital
Phase
Observational
Overall status
Not yet recruiting
Start date
January 31, 2026
Completion date
January 31, 2027
Enrollment
165 (estimated)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

breast cancer early stage breast cancer (stage 1-3)